<SEC-DOCUMENT>0001737287-21-000010.txt : 20210225
<SEC-HEADER>0001737287-21-000010.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225170215
ACCESSION NUMBER:		0001737287-21-000010
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
REFERENCES 429:			333-227965
REFERENCES 429:			333-230164
REFERENCES 429:			333-236701
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225
EFFECTIVENESS DATE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253530
		FILM NUMBER:		21681419

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>allogene-formsx8x20210225.htm
<DESCRIPTION>S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ifc338afece704977a830bbc9c22b79ac_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As filed with the Securities and Exchange Commission on February 25, 2021 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration No. 333-</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">_________________________________</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">UNDER </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%">Allogene Therapeutics, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">________________________________</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.264%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82-3562771</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction of</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">incorporation or organization)</font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(I.R.S. Employer</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">210 East Grand Avenue</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">South San Francisco, California</font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94080</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amended and Restated 2018 Equity Incentive Plan </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 Employee Stock Purchase Plan </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Full titles of the plans)</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David Chang, M.D., Ph.D. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">President and Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allogene Therapeutics, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">210 East Grand Avenue </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">South San Francisco, California 94080 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(650) 457-2700 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Name, address, including zip code, and telephone number, including area code, of agent for service) </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Copies to&#58; </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charles J Bair, Esq. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cooley LLP </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4401 Eastgate Mall </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">San Diego, California 92121 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(858) 550-6000 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">________________________________</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.196%"><tr><td style="width:1.0%"></td><td style="width:29.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.648%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Accelerated filer</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744; </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">________________________________</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CALCULATION OF REGISTRATION FEE </font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.428%"><tr><td style="width:1.0%"></td><td style="width:2.449%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.154%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:34.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.480%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.799%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="9" style="border-bottom:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Securities&#160;to be Registered</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount&#160;</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">to be<br>Registered </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proposed<br>Maximum<br>Offering Price<br>Per Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proposed<br>Maximum<br>Aggregate</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Offering Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount of</font></div><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration Fee</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amended and Restated 2018 Equity Incentive Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock, $0.001 par value per share</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,023,715</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33.29</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$233,819,472</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,509.71</font></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 Employee Stock Purchase Plan </font></div><div style="padding-left:10pt;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock, $0.001 par value per share</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,404,743</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33.29</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46,763,894</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,101.94</font></td></tr><tr><td colspan="9" style="border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,428,458</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$280,583,367</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$30,611.65</font></td></tr><tr style="height:5pt"><td colspan="9" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of common stock (&#8220;Common Stock&#8221;) of Allogene Therapeutics, Inc. (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s Amended and Restated 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) or the Registrant&#8217;s 2018 Employee Stock Purchase Plan (the &#8220;2018 ESPP&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This estimate is made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Common Stock on February 23, 2021, as reported on the Nasdaq Global Select Market.</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2018 Plan on January 1, 2021 pursuant to an &#8220;evergreen&#8221; provision contained in the 2018 Plan. Pursuant to such provision, on January 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year through January 1, 2028, the number of shares authorized for issuance under the 2018 Plan will be automatically increased by&#58; (a) 5% of the total number of shares of capital stock of the Registrant outstanding on December 31 of the preceding calendar year&#59; or (b) such lesser number of shares of Common Stock as the Registrant&#8217;s board of directors (the &#8220;Board&#8221;) may designate prior to the applicable January 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2018 ESPP on January 1, 2021 pursuant to an &#8220;evergreen&#8221; provision contained in the 2018 ESPP. Pursuant to such provision, on January 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year through January 1, 2028, the number of shares authorized for issuance under the 2018 ESPP will be automatically increased by a number equal to the lesser of&#58; (a) 1% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year&#59; (b) 2,320,000 shares&#59; and (c) such lesser number of shares of Common Stock as the Board may designate prior to the applicable January 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div></td></tr><tr style="height:12pt"><td colspan="33" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="9" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCORPORATION OF DOCUMENTS BY REFERENCE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement of the Registrant on Form S-8 relating to the same employee benefit plan is effective.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Registrant previously registered shares of Common Stock for issuance under the 2018 Plan and 2018 ESPP under Registration Statements on Form S-8 filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1737287/000119312518306372/d642001ds8.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">October 24, 2018</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (File No. 333-227965), </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1737287/000119312519069173/d720187ds8.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">March 8, 2019</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (File No. 333-230164) and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1737287/000173728720000013/allogene-formsx8x02272020.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">February 27, 2020</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (File No. 333-236701). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:7.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM&#160;8.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBITS.</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:7.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.359%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex31.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amended and Restated Certificate of Incorporation of the Registrant.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1737287/000119312518299356/d622265dex32.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amended and Restated Bylaws of the Registrant.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1737287/000119312518290441/d548088dex41.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Common Stock Certificate of the Registrant.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit51-formsx8x20210225.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Opinion of Cooley LLP.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit231-formsx8x20210225.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of</a><a href="exhibit231-formsx8x20210225.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </a><a href="exhibit231-formsx8x20210225.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Registered Public Accounting Firm</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Cooley LLP. Reference is made to Exhibit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="exhibit51-formsx8x20210225.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5.1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ifc338afece704977a830bbc9c22b79ac_4" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Power of Attorney. Reference is made to the signature page hereto.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1737287/000119312518306372/d642001dex992.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement thereunder.</a></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td><td colspan="6" style="background-color:#ffffff;padding:0 1pt"><div><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1737287/000119312518306372/d642001dex993.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Allogene Therapeutics, Inc. 2018 Employee Stock Purchase Plan.</a></font></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously filed as Exhibit 3.1 to the Registrant&#8217;s Current Report on Form&#160;8-K&#160;(File&#160;No.&#160;001-38693),&#160;filed with the Commission on October&#160;15, 2018 and incorporated herein by reference.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously filed as Exhibit 3.2 to the Registrant&#8217;s Current Report on Form&#160;8-K&#160;(File&#160;No.&#160;001-38693),&#160;filed with the Commission on October&#160;15, 2018 and incorporated herein by reference.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously filed as Exhibit 4.1 to the Registrant&#8217;s Registration Statement on Form&#160;S-1&#160;(File&#160;No.&#160;333-227333),&#160;originally filed with the Commission on September&#160;14, 2018, as amended, and incorporated herein by reference.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously filed as Exhibit 99.2 to the Registrant&#8217;s Registration Statement on Form&#160;S-8&#160;(File&#160;No.&#160;333-227965),&#160;filed with the Commission on October&#160;24, 2018, and incorporated herein by reference.</font></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)&#160;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously filed as Exhibit 99.3 to the Registrant&#8217;s Registration Statement on Form&#160;S-8&#160;(File&#160;No.&#160;333-227965), filed with the Commission on October&#160;24, 2018, and incorporated herein by reference.</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifc338afece704977a830bbc9c22b79ac_4"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of South San Francisco, State of California, on February 25, 2021. </font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Allogene Therapeutics,&#160;Inc.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; David Chang, M.D., Ph.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Chang, M.D., Ph.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Chief Executive Officer and Member of the Board of Directors</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Chang, M.D., Ph.D., and Eric Schmidt, Ph.D., and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. </font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:83%">Date</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Chang, M.D., Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">President, Chief Executive Officer <br>and Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">David Chang, M.D., Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:83%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eric Schmidt, Ph.D.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Eric Schmidt, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:83%">Principal Financial and Accounting Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Arie Belldegrun, M.D., FACS</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Executive Chairman of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Arie Belldegrun, M.D., FACS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Bonderman</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">David Bonderman</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John DeYoung</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">John DeYoung</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Franz Humer, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Franz Humer, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joshua Kazam</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Joshua Kazam</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Deborah M. Messemer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Deborah M. Messemer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Todd Sisitsky</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Todd Sisitsky</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Owen Witte, M.D.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Member of the Board of Directors</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">February 25, 2021</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Owen Witte, M.D.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231-formsx8x20210225.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6da172cc630d406386fc3f7969eecf17_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Amended and Restated 2018 Equity Incentive Plan and 2018 Employee Stock Purchase Plan of Allogene Therapeutics, Inc. of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our reports dated February 25, 2021, with respect to the consolidated financial statements of Allogene Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Allogene Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2020</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, filed with the Securities and Exchange Commission.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Jose, California</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 25, 2021</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-formsx8x20210225.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i214dd47f23964352b7a9c39921fa8f7c_1"></div><div style="min-height:108pt;width:100%"><div style="margin-bottom:15pt;padding-right:5.4pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div><div style="padding-right:5.4pt"><img alt="cooley1.jpg" src="cooley1.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:150px"></div></div><div style="padding-right:5.4pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Charles J. Bair</font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:120%">+1 858 550 6142</font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:120%">cbair&#64;cooley.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February 25, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Allogene Therapeutics, Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">210 East Grand Avenue</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">South San Francisco, California 94080</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">You have requested our opinion, as counsel to Allogene Therapeutics, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), in connection with the filing by the Company of a Registration Statement on Form S-8 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Registration Statement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) with the Securities and Exchange Commission covering the offering of up to 8,428,458 shares (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) of the Company's Common Stock, par value $0.001 per share (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), including (i) 7,023,715 shares of Common Stock issuable pursuant to the Company&#8217;s Amended and Restated 2018 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Incentive Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) and (ii) 1,404,743 shares of Common Stock issuable pursuant to the Company&#8217;s 2018 Employee Stock Purchase Plan (together with the Incentive Plan, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with this opinion, we have examined and relied upon the Registration Statement and related prospectuses, the Plans, the Company&#8217;s Certificate of Incorporation and Bylaws, each as currently in effect, and originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below.  We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials&#59; and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness of such documents. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Plans, the Registration Statement and related prospectuses, will be validly issued, fully paid and nonassessable (except as to Shares issued pursuant to certain deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the filing of this opinion as an exhibit to the Registration Statement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sincerely,</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cooley LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Charles J. Bair                           </font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Charles J. Bair</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:7pt;font-weight:400;line-height:115%">4401 EASTGATE MALL, SAN DIEGO, CA 92121  T&#58; (858) 550-6000  F&#58; (858) 550-6420  WWW.COOLEY.COM</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cooley1.jpg
<TEXT>
begin 644 cooley1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Z 5@# 2(  A$! Q$!_\0
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M0WQHO?C9\0;K5'=X]'MBUOIEJ3Q'"#]XC^\_WC^ Z 5][_M@^+)/"?P \2/
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M:/RC-O\ C#.*_;X56IW4K?W9?%'\TNUD?CEX9\1WWA'Q%INMZ9+Y%_I]PES
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M=:K&C!SD<N3Y77SG'4\'05W)Z^2ZM^27^6Y^>;$,Q(&T$\ =J_27]@^WE@^
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MJ**^FIP5.*A'9'\R8[&5<PQ53%UW>4VV_G^BZ!1115G"%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %07RW$EE<+:2)%=-&PBDD7<JO@[21W ..*GHH&G9
MW/B+4/\ @GAK6JW]S>WGQ M[B[N96FFFDTYBSNQ)9C^\ZDDFOH+]G'X VWP#
M\+W]A]N35M2O[CSKB]6'RLJHPB 9/"_,>O5S7K=%<=/"4:4N>"U/K\RXMSC-
?L,\'BZUZ;MHHQ6VVR7W!11178?'A1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
